SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Iamarangerboy who wrote (9471)5/24/2006 4:51:59 PM
From: Iamarangerboy  Read Replies (1) | Respond to of 10280
 
this may be the etiology of the strength....
Sepracor Presents Arformoterol Data at American Thoracic Society International Conference
Wednesday May 24, 4:30 pm ET

MARLBOROUGH, Mass.--(BUSINESS WIRE)--May 24, 2006--Sepracor Inc. (Nasdaq: SEPR - News) today announced that it presented two arformoterol tartrate inhalation solution posters at the International Conference of the American Thoracic Society (ATS) in San Diego.

biz.yahoo.com